Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$793,656
+$42,981 QoQ
Shares Held
3,125
+1.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#3,237
of 4,664 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Quantum Portfolio Management LLC holds $3,261,987 across 8 Drug Manufacturers - General names. JNJ ranks #1 (24.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
3,125 | $793,656 | |
| 2 | AZN |
Astrazeneca PLC
|
3,012 | $571,135 | |
| 3 | NVS |
Novartis AG
|
3,206 | $502,443 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
3,618 | $457,098 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,465 | $316,752 | |
| 6 | LLY |
ELI LILLY & Co
|
239 | $286,663 | |
| 7 | ABBV |
AbbVie Inc.
|
744 | $187,220 | |
| 8 | AMGN |
Amgen Inc
|
406 | $147,020 |
All Filings in JNJ
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $793,656 | 3,125 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $750,675 | 3,071 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $497,300 | 2,403 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $323,372 | 1,744 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $265,632 | 1,739 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $340,137 | 2,051 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $448,900 | 3,104 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $696,533 | 4,298 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $516,090 | 3,531 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $586,568 | 3,708 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $433,072 | 2,763 | Shares | Sole | 2024-01-26 | |
| No filing history on record for this holder in this stock. | ||||||